The novel agent, DISC-0974, demonstrates high specificity for RGMC, a essential protein playing during human development. Early studies indicate that inhibiting RGMC/HFE2 activity with this molecule leads in decreased tumor proliferation and ameliorates symptoms severity of multiple disease model… Read More

Vibostolimab | a | the | this novel | new | emerging antibody | therapeutic | agent represents a | an significant | important | critical advance | step | development in immunotherapy | cancer treatment | therapy. Targeting | focusing | blocking TIGIT, a | an inhibitory | negative | suppressive re… Read More